The completion of the Human Genome has given geneticists an ecyclopedia to study from. People now have the option have direct-to-consumer genomic profiling and interpretations. The article also addresses some ethical and legal issues. For example, there may be certain ethnicity-specific responses to certain drugs. If pharmacogenomics progesses to quickly, there may be legal issues because of these ehtnic concerns. In addition, certain environments may affect different people's response to the drug, and perhaps the drug's toxicity.
With the development of pharmacogenomics, how will we store all the personal data collected from DNA sequencing? Imagine how much more data needs to be stored. Currently, we have folders and medical files for everyone. With the development of personalized medicine, we will have to have massive electrical medical record storing devices for the billions of genetic profiles on record. Furthermore, there will probably be a need for analytical devices to predict the effectiveness of certain drugs based on a specific personal profile.
The article also addresses the fact that not only the average person needs to be educated in the field of pharmacogenomics, but also health care professionals. Publicity in the field of personalized medicine will also start to grow so journalists should know what they're talking about.
The next step for personalized medicine is to enter the early stages of clinical research and diagnostics. This will help to develop treatment strategies for certain people or certain groups of people.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment